These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 12973188

  • 1. Antibiotic tissue concentrations revisited in lungs.
    Bergogne-Berezin E.
    Crit Care Med; 2003 Aug; 31(8):2242-3. PubMed ID: 12973188
    [No Abstract] [Full Text] [Related]

  • 2. [Differential use of cephalosporins in treatment of upper and lower respiratory tract infections].
    Dvoretskiĭ LI, Omel'ianovskiĭ VV.
    Antibiot Khimioter; 1998 Aug; 43(6):24-8. PubMed ID: 9644531
    [No Abstract] [Full Text] [Related]

  • 3. Ceftobiprole medocaril (Mabelio). Just another injectable cephalosporin.
    Prescrire Int; 2015 Nov; 24(165):260. PubMed ID: 26688892
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Ceftaroline fosamil (Teflaro) - a new IV cephalosporin.
    Med Lett Drugs Ther; 2011 Jan 24; 53(1356):5-6. PubMed ID: 21252841
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pharmacokinetic/pharmacodynamic analysis to evaluate ceftaroline fosamil dosing regimens for the treatment of community-acquired bacterial pneumonia and complicated skin and skin-structure infections in patients with normal and impaired renal function.
    Canut A, Isla A, Rodríguez-Gascón A.
    Int J Antimicrob Agents; 2015 Apr 24; 45(4):399-405. PubMed ID: 25700566
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Ceftaroline (Teflaro): a new cephalosporin.
    Belavic JM.
    Nurse Pract; 2011 Nov 24; 36(11):12-3. PubMed ID: 22008594
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The penetration of novel intravenous cephalosporins into the lung.
    Baldwin DR.
    J Chemother; 1996 Feb 24; 8 Suppl 2():71-82. PubMed ID: 8738849
    [Abstract] [Full Text] [Related]

  • 12. Cefepime versus ceftazidime: considerations for empirical use in critically ill patients.
    Roberts JA, Webb SA, Lipman J.
    Int J Antimicrob Agents; 2007 Feb 24; 29(2):117-28. PubMed ID: 17158033
    [Abstract] [Full Text] [Related]

  • 13. The role of cefditoren in the treatment of lower community-acquired respiratory tract infections (LRTIs): from bacterial eradication to reduced lung inflammation and epithelial damage.
    Di Marco F, Braido F, Santus P, Scichilone N, Blasi F.
    Eur Rev Med Pharmacol Sci; 2014 Feb 24; 18(3):321-32. PubMed ID: 24563430
    [Abstract] [Full Text] [Related]

  • 14. [Cephalosporins and community-acquired pneumonia: a choice alternative].
    Zubkov MN.
    Antibiot Khimioter; 2005 Feb 24; 50(2-3):73-8. PubMed ID: 16308943
    [No Abstract] [Full Text] [Related]

  • 15. Activity of cefepime and carbapenems in experimental pneumonia caused by porin-deficient Klebsiella pneumoniae producing FOX-5 beta-lactamase.
    Pichardo C, del Carmen Conejo M, Bernabéu-Wittel M, Pascual A, Jiménez-Mejías ME, de Cueto M, Pachón-Ibáñez ME, García I, Pachón J, Martínez-Martínez L.
    Clin Microbiol Infect; 2005 Jan 24; 11(1):31-8. PubMed ID: 15649301
    [Abstract] [Full Text] [Related]

  • 16. Ceftobiprole for the treatment of pneumonia: a European perspective.
    Liapikou A, Cillóniz C, Torres A.
    Drug Des Devel Ther; 2015 Jan 24; 9():4565-72. PubMed ID: 26316697
    [Abstract] [Full Text] [Related]

  • 17. Intrapulmonary concentrations of cefepime.
    De Rosa FG, Zeme D, Bargiacchi O, Audagnotto S, Bonora S, Di Perri G.
    Crit Care Med; 2004 May 24; 32(5):1238; author reply 1238-9. PubMed ID: 15190988
    [No Abstract] [Full Text] [Related]

  • 18. [Stepwise therapy of community-acquired pneumonia. Results of cefuroxime and cefuroxime axetil study].
    Iakovlev SV, Suvorova MP, Dvoretskiĭ LI, Vlasenko NA, Shakhova TV.
    Antibiot Khimioter; 1998 May 24; 43(6):7-11. PubMed ID: 9644527
    [Abstract] [Full Text] [Related]

  • 19. Cefepime free minimum concentration to minimum inhibitory concentration (fCmin/MIC) ratio predicts clinical failure in patients with Gram-negative bacterial pneumonia.
    Aitken SL, Altshuler J, Guervil DJ, Hirsch EB, Ostrosky-Zeichner LL, Ericsson CD, Tam VH.
    Int J Antimicrob Agents; 2015 May 24; 45(5):541-4. PubMed ID: 25665726
    [Abstract] [Full Text] [Related]

  • 20. Integrated analysis of FOCUS 1 and FOCUS 2: randomized, doubled-blinded, multicenter phase 3 trials of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in patients with community-acquired pneumonia.
    File TM, Low DE, Eckburg PB, Talbot GH, Friedland HD, Lee J, Llorens L, Critchley I, Thye D.
    Clin Infect Dis; 2010 Dec 15; 51(12):1395-405. PubMed ID: 21067350
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.